18 Mar, 2024 What every Life Sciences lawyer needs (commercial contracts) By DLA Piper Life Sciences Welcome to ‘What every Life Sciences lawyer needs (Commercial Contracts)’, a series in which DLA Piper’s Life Sciences team help you, the...
13 Mar, 2024 Celebrating Inspirational Women in Life Sciences: Elena Coluccelli-Guerin, bridging finance and life sciences By Marion Abecassis In the fast-evolving landscape of life sciences, individuals like Elena Coluccelli Guerin, Co-Head of the Healthcare and Life Sciences...
12 Mar, 2024 Life Sciences Regulation in the EU: Overview By Marco de Morpurgo Nicola Landolfi Nadia Feola Heidi Waem +1 more... Show less DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU...
08 Mar, 2024 IWD: Inspirational Women in Life Sciences Series 2024 By Hannah Gardiner Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature inspirational women working in the Life Sciences sector....
07 Mar, 2024 Could PISCES be written in your stars or are you simply in need of a funding LIFT[S]? By Robert Newman Spring Budgets in the UK are not necessarily bookmark events in the calendar of Life Sciences lawyers. However, with a frost still on the...
28 Feb, 2024 China’s healthcare anti-corruption campaign continues its momentum in 2024: key takeaways for life sciences companies By Christine Liu In July 2023, China launched a sweeping national campaign against healthcare corruption. Since then, the National Health Commission...
21 Feb, 2024 Italy: Medical Device Governance Fund: Ministry of Health sets out how companies in the sector will pay 0.75% of turnover By Giorgia Romitelli Roberta Moffa With the decree of 29 December 2023, published in the Italian Official Gazette on 9 February 2024, the Ministry of Health has established...
20 Feb, 2024 Gene drives: Genetic engineering without risk? By Pia Riemenschneider Elisa Winkels Mikael Kurki What if a new method of genetic engineering could eliminate life-threatening diseases like malaria? What if we could increase crop yields...
19 Feb, 2024 FDA’s new Quality Management System Regulation is here: Key takeaways for device companies in US, EU, and China By Bethany Hills Christopher Mikson Perham Gorji Jae Kim Adam Donat Marco de Morpurgo Ting Xiao +4 more... Show less On January 21, 2024, the FDA issued a final rule amending its Quality System (QS) regulations under 21 CFR Part 820, which addresses...
12 Feb, 2024 ABPI Manifesto for Investment, Health and Growth By Martha Pownall Richard Taylor Earlier this month, the Association of the British Pharmaceutical Industry (ABPI) launched their "ABPI manifesto for investment, health...
05 Feb, 2024 A patent perspective on the battle against cancer By Rebecca Lawrence 4 February is World Cancer Day, an international day marked to raise awareness of cancer and to encourage its prevention, detection, and...
30 Jan, 2024 Regulation of Life Sciences AI in Australia By Nicholas Tyacke Alexandra de Zwart Alex Horder Jordan Davis +1 more... Show less In an important development for life sciences and healthcare companies (et al), on 17 January 2024 and after receiving over 500...
29 Jan, 2024 Commission report finds active competition enforcement continues to contribute to affordable and innovative medicines By Joost Haans Anna Sacco On 26 January 2024, the European Commission published a report providing an overview of the enforcement of EU antitrust and merger rules...
23 Jan, 2024 “March-in” rights and life sciences inventions in Australia: Is the position in Australia the same as under the US Bayh-Dole Act? By Nicholas Tyacke Greg Bodulovic Jess McKenna Recent statements and actions by the US Biden Administration regarding march-in rights and drug pricing have made these issues a hot...
23 Jan, 2024 Understanding what is happening in the life sciences, healthcare and cannabis market in Brazil in 2024 and why By Bruna Rocha Victoria Cristofaro Juliana Marcondes Transactional. The years 2022 and 2023 presented significant challenges for the industry, with a post-pandemic market correction and...
15 Jan, 2024 Poland - Life Sciences Monthly Brief, December 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our December monthly briefing, which covers key updates and insights in the following areas: Medical products;...
08 Jan, 2024 Portugal | Removal of the retail price of medicines from labelling and packaging By Mariana Ricardo Since 2006, when the Medicines Code was approved in Portugal, marketing authorisation holders had to include the retail selling price of...